ResMed Inc. Website

ResMed Inc.

NYSE-RMD

Income Statement
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24

Total Revenues

2,957

3,196.8

3,578.1

4,223

4,685.3

Total Revenues % Chg.

13.4%

8.1%

11.9%

18%

10.9%

Cost of Goods Sold, Total

1,189.6

1,307.4

1,514.2

1,836.9

1,997

Gross Profit

1,767.4

1,889.4

2,064

2,386.1

2,688.3

Selling General & Admin Expenses, Total

676.7

670.4

737.5

874

917.1

R&D Expenses

201.9

225.3

253.6

287.6

307.5

Amortization of Goodwill and Intangible Assets

79.7

76.2

70.7

72.4

79.5

Other Operating Expenses, Total

958.3

971.9

1,061.8

1,234.1

1,304.1

Operating Income

809.1

917.6

1,002.2

1,152

1,384.1

Interest Expense, Total

-39.4

-23.6

-22.3

-51.1

-49.7

Interest And Investment Income

—

—

—

—

—

Net Interest Expenses

-39.4

-23.6

-22.3

-51.1

-49.7

Income (Loss) On Equity Invest.

—

—

—

—

-25.1

-11.2

-8.5

-7.3

-1.8

Currency Exchange Gains (Loss)

—

-0.8

2.8

-0.5

-0.1

Other Non Operating Income (Expenses)

2.4

1.1

0.4

-1.5

0.7

EBT, Excl. Unusual Items

747

883

974.5

1,091.6

1,333.1

Restructuring Charges

—

—

-13.9

—

-9.2

-64.2

Merger & Related Restructuring Charges

—

—

—

—

—

-1.9

-10.9

—

Gain (Loss) On Sale Of Investments

—

-14.5

14.5

-12.2

9.9

-4

Insurance Settlements

—

—

—

—

—

—

—

—

20.2

—

Legal Settlements

—

—

—

0.6

—

—

—

—

EBT, Incl. Unusual Items

733.1

883.7

960.5

1,101.7

1,264.8

Income Tax Expense

111.4

409.2

181

204.1

243.8

Earnings From Continuing Operations

621.7

474.5

779.4

897.6

1,021

Net Income

621.7

474.5

779.4

897.6

1,021

Net Income to Common Incl Extra Items

621.7

474.5

779.4

897.6

1,021

Net Income to Common Excl. Extra Items

621.7

474.5

779.4

897.6

1,021

Total Shares Outstanding

144.9

145.6

146.4

147.1

146.9

Weighted Avg. Shares Outstanding

144.3

145.3

146.1

146.8

147

Weighted Avg. Shares Outstanding Dil

145.7

146.5

147

147.5

147.6

EPS

4.3

3.3

5.3

6.1

6.9

EPS Diluted

4.3

3.2

5.3

6.1

6.9

EBITDA

922.9

1,029

1,126.2

1,292.1

1,533.5

Effective Tax Rate

15.2%

46.3%

18.8%

18.5%

19.3%